NFS1 undergoes positive selection in lung tumours and protects cells from ferroptosis.

Nature
Authors
Keywords
Abstract

Environmental nutrient levels impact cancer cell metabolism, resulting in context-dependent gene essentiality. Here, using loss-of-function screening based on RNA interference, we show that environmental oxygen levels are a major driver of differential essentiality between in vitro model systems and in vivo tumours. Above the 3-8% oxygen concentration typical of most tissues, we find that cancer cells depend on high levels of the iron-sulfur cluster biosynthetic enzyme NFS1. Mammary or subcutaneous tumours grow despite suppression of NFS1, whereas metastatic or primary lung tumours do not. Consistent with a role in surviving the high oxygen environment of incipient lung tumours, NFS1 lies in a region of genomic amplification present in lung adenocarcinoma and is most highly expressed in well-differentiated adenocarcinomas. NFS1 activity is particularly important for maintaining the iron-sulfur co-factors present in multiple cell-essential proteins upon exposure to oxygen compared to other forms of oxidative damage. Furthermore, insufficient iron-sulfur cluster maintenance robustly activates the iron-starvation response and, in combination with inhibition of glutathione biosynthesis, triggers ferroptosis, a non-apoptotic form of cell death. Suppression of NFS1 cooperates with inhibition of cysteine transport to trigger ferroptosis in vitro and slow tumour growth. Therefore, lung adenocarcinomas select for expression of a pathway that confers resistance to high oxygen tension and protects cells from undergoing ferroptosis in response to oxidative damage.

Year of Publication
2017
Journal
Nature
Volume
551
Issue
7682
Pages
639-643
Date Published
2017 11 30
ISSN
1476-4687
DOI
10.1038/nature24637
PubMed ID
29168506
PubMed Central ID
PMC5808442
Links
Grant list
CA168940 / NH / NIH HHS / United States
R01 CA103866 / CA / NCI NIH HHS / United States
S10 OD010584-01 / NH / NIH HHS / United States
K22 CA193660 / CA / NCI NIH HHS / United States
P30 CA016087 / CA / NCI NIH HHS / United States
K99 CA168940 / CA / NCI NIH HHS / United States
S10 OD016304 / OD / NIH HHS / United States
T32 GM115313 / GM / NIGMS NIH HHS / United States
T32 GM007308 / GM / NIGMS NIH HHS / United States
S10 OD018338 / OD / NIH HHS / United States
R37 AI047389 / AI / NIAID NIH HHS / United States
S10 OD010584 / OD / NIH HHS / United States
R01 CA129105 / CA / NCI NIH HHS / United States
R00 CA168940 / CA / NCI NIH HHS / United States
T32 AI007389 / AI / NIAID NIH HHS / United States